Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

LAT1-specific inhibitor is effective against T cell-mediated allergic skin inflammation.

Hayashi K, Kaminuma O, Nishimura T, Saeki M, Matsuoka K, Hiroi T, Jutabha P, Iwata Y, Sugiura K, Owada T, Kurasawa K, Okayasu I, Ouchi M, Fujita T, Kanai Y, Endou H, Anzai N.

Allergy. 2019 Aug 12. doi: 10.1111/all.14019. [Epub ahead of print] No abstract available.

PMID:
31403710
2.

The uricosuric effects of dihydropyridine calcium channel blockers in vivo using urate under-excretion animal models.

Hori T, Ouchi M, Otani N, Nohara M, Morita A, Otsuka Y, Jutabha P, Shibasaki I, Matsushita Y, Fujita T, Fukuda H, Anzai N.

J Pharmacol Sci. 2018 Apr;136(4):196-202. doi: 10.1016/j.jphs.2017.11.011. Epub 2018 Mar 8.

3.

Catalytic asymmetric synthesis of α-methyl-p-boronophenylalanine.

Harada S, Kajihara R, Muramoto R, Jutabha P, Anzai N, Nemoto T.

Bioorg Med Chem Lett. 2018 Jun 1;28(10):1915-1918. doi: 10.1016/j.bmcl.2018.03.075. Epub 2018 Mar 28.

PMID:
29655983
4.

Uric acid lowering in relation to HbA1c reductions with the SGLT2 inhibitor tofogliflozin.

Ouchi M, Oba K, Kaku K, Suganami H, Yoshida A, Fukunaka Y, Jutabha P, Morita A, Otani N, Hayashi K, Fujita T, Suzuki T, Yasutake M, Anzai N.

Diabetes Obes Metab. 2018 Apr;20(4):1061-1065. doi: 10.1111/dom.13170. Epub 2018 Jan 8.

5.

Inhibition of l-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment.

Yothaisong S, Dokduang H, Anzai N, Hayashi K, Namwat N, Yongvanit P, Sangkhamanon S, Jutabha P, Endou H, Loilome W.

Tumour Biol. 2017 Mar;39(3):1010428317694545. doi: 10.1177/1010428317694545.

PMID:
28347255
6.

Roles of organic anion transporters (OATs) in renal proximal tubules and their localization.

Otani N, Ouchi M, Hayashi K, Jutabha P, Anzai N.

Anat Sci Int. 2017 Mar;92(2):200-206. doi: 10.1007/s12565-016-0369-3. Epub 2016 Sep 10. Review.

PMID:
27614971
7.

LAT1 acts as a crucial transporter of amino acids in human thymic carcinoma cells.

Hayashi K, Jutabha P, Maeda S, Supak Y, Ouchi M, Endou H, Fujita T, Chida M, Anzai N.

J Pharmacol Sci. 2016 Nov;132(3):201-204. doi: 10.1016/j.jphs.2016.07.006. Epub 2016 Jul 27.

8.

Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance.

Yothaisong S, Namwat N, Yongvanit P, Khuntikeo N, Puapairoj A, Jutabha P, Anzai N, Tassaneeyakul W, Tangsucharit P, Loilome W.

Parasitol Int. 2017 Aug;66(4):471-478. doi: 10.1016/j.parint.2015.11.011. Epub 2015 Nov 30.

PMID:
26657242
9.

Interaction of green tea catechins with renal organic cation transporter 2.

Jaiyen C, Jutabha P, Anzai N, Lungkaphin A, Soodvilai S, Srimaroeng C.

Xenobiotica. 2016 Jul;46(7):641-650. doi: 10.3109/00498254.2015.1107785. Epub 2015 Nov 17.

PMID:
26576923
10.

Distinct action of the α-glucosidase inhibitor miglitol on SGLT3, enteroendocrine cells, and GLP1 secretion.

Lee EY, Kaneko S, Jutabha P, Zhang X, Seino S, Jomori T, Anzai N, Miki T.

J Endocrinol. 2015 Mar;224(3):205-14. doi: 10.1530/JOE-14-0555. Epub 2014 Dec 8.

11.

LAT1 is a central transporter of essential amino acids in human umbilical vein endothelial cells.

Hayashi K, Jutabha P, Kamai T, Endou H, Anzai N.

J Pharmacol Sci. 2014;124(4):511-3. Epub 2014 Mar 27.

12.

LAT1 is a critical transporter of essential amino acids for immune reactions in activated human T cells.

Hayashi K, Jutabha P, Endou H, Sagara H, Anzai N.

J Immunol. 2013 Oct 15;191(8):4080-5. doi: 10.4049/jimmunol.1300923. Epub 2013 Sep 13.

13.

Potent human uric acid transporter 1 inhibitors: in vitro and in vivo metabolism and pharmacokinetic studies.

Wempe MF, Lightner JW, Miller B, Iwen TJ, Rice PJ, Wakui S, Anzai N, Jutabha P, Endou H.

Drug Des Devel Ther. 2012;6:323-39. doi: 10.2147/DDDT.S35805. Epub 2012 Nov 8.

14.

Atypical Leydig cell hyperplasia in adult rats with low T and high LH induced by prenatal Di(n-butyl) phthalate exposure.

Wakui S, Takahashi H, Mutou T, Shirai M, Jutabha P, Anzai N, Wempe MF, Kansaku N, Hano H, Inomata T, Endou H.

Toxicol Pathol. 2013;41(3):480-6. doi: 10.1177/0192623312457272. Epub 2012 Sep 11.

PMID:
22968287
15.

c-Myc is crucial for the expression of LAT1 in MIA Paca-2 human pancreatic cancer cells.

Hayashi K, Jutabha P, Endou H, Anzai N.

Oncol Rep. 2012 Sep;28(3):862-6. doi: 10.3892/or.2012.1878. Epub 2012 Jun 20.

PMID:
22736142
16.

Sex-associated difference in estrogen receptor β expression in N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric cancers in rats.

Wakui S, Motohashi M, Muto T, Takahashi H, Hano H, Jutabha P, Anzai N, Wempe MF, Endou H.

Comp Med. 2011 Oct;61(5):412-8.

17.

Clinical and functional characterization of URAT1 variants.

Tasic V, Hynes AM, Kitamura K, Cheong HI, Lozanovski VJ, Gucev Z, Jutabha P, Anzai N, Sayer JA.

PLoS One. 2011;6(12):e28641. doi: 10.1371/journal.pone.0028641. Epub 2011 Dec 16.

18.

Human uric acid transporter 1 (hURAT1): an inhibitor structure-activity relationship (SAR) study.

Wempe MF, Quade B, Jutabha P, Iwen T, Frick M, Rice PJ, Wakui S, Endou H.

Nucleosides Nucleotides Nucleic Acids. 2011 Dec;30(12):1312-23. doi: 10.1080/15257770.2011.594031.

PMID:
22132992
19.

Apical voltage-driven urate efflux transporter NPT4 in renal proximal tubule.

Jutabha P, Anzai N, Wempe MF, Wakui S, Endou H, Sakurai H.

Nucleosides Nucleotides Nucleic Acids. 2011 Dec;30(12):1302-11. doi: 10.1080/15257770.2011.616564. Review.

PMID:
22132991
20.

Increased expression of SLC2A9 decreases urate excretion from the kidney.

Kimura T, Amonpatumrat S, Tsukada A, Fukutomi T, Jutabha P, Thammapratip T, Lee EJ, Ichida K, Anzai N, Sakurai H.

Nucleosides Nucleotides Nucleic Acids. 2011 Dec;30(12):1295-301. doi: 10.1080/15257770.2011.628354.

PMID:
22132990
21.

Recent advances in renal urate transport: characterization of candidate transporters indicated by genome-wide association studies.

Anzai N, Jutabha P, Amonpatumrat-Takahashi S, Sakurai H.

Clin Exp Nephrol. 2012 Feb;16(1):89-95. doi: 10.1007/s10157-011-0532-z. Epub 2011 Nov 1. Review.

PMID:
22038265
22.

Metabolism and pharmacokinetic studies of JPH203, an L-amino acid transporter 1 (LAT1) selective compound.

Wempe MF, Rice PJ, Lightner JW, Jutabha P, Hayashi M, Anzai N, Wakui S, Kusuhara H, Sugiyama Y, Endou H.

Drug Metab Pharmacokinet. 2012;27(1):155-61. Epub 2011 Sep 13.

23.

A novel human organic anion transporter NPT4 mediates the transport of ochratoxin A.

Jutabha P, Anzai N, Hayashi K, Domae M, Uchida K, Endou H, Sakurai H.

J Pharmacol Sci. 2011;116(4):392-6. Epub 2011 Jul 21.

24.

Developing potent human uric acid transporter 1 (hURAT1) inhibitors.

Wempe MF, Jutabha P, Quade B, Iwen TJ, Frick MM, Ross IR, Rice PJ, Anzai N, Endou H.

J Med Chem. 2011 Apr 28;54(8):2701-13. doi: 10.1021/jm1015022. Epub 2011 Mar 30.

25.

Human urate transporter 1 (hURAT1) mediates the transport of orotate.

Miura D, Anzai N, Jutabha P, Chanluang S, He X, Fukutomi T, Endou H.

J Physiol Sci. 2011 May;61(3):253-7. doi: 10.1007/s12576-011-0136-0. Epub 2011 Feb 25.

PMID:
21350910
26.

Functional analysis of human sodium-phosphate transporter 4 (NPT4/SLC17A3) polymorphisms.

Jutabha P, Anzai N, Kimura T, Taniguchi A, Urano W, Yamanaka H, Endou H, Sakurai H.

J Pharmacol Sci. 2011;115(2):249-53. Epub 2011 Jan 26.

27.

Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate.

Jutabha P, Anzai N, Kitamura K, Taniguchi A, Kaneko S, Yan K, Yamada H, Shimada H, Kimura T, Katada T, Fukutomi T, Tomita K, Urano W, Yamanaka H, Seki G, Fujita T, Moriyama Y, Yamada A, Uchida S, Wempe MF, Endou H, Sakurai H.

J Biol Chem. 2010 Nov 5;285(45):35123-32. doi: 10.1074/jbc.M110.121301. Epub 2010 Sep 1.

28.

Concentration-dependent inhibitory effect of irbesartan on renal uric acid transporters.

Nakamura M, Anzai N, Jutabha P, Sato H, Sakurai H, Ichida K.

J Pharmacol Sci. 2010;114(1):115-8. Epub 2010 Aug 21.

29.

Molecular mechanism of ochratoxin a transport in the kidney.

Anzai N, Jutabha P, Endou H.

Toxins (Basel). 2010 Jun;2(6):1381-98. doi: 10.3390/toxins2061381. Epub 2010 Jun 9.

30.

A novel transporter of SLC22 family specifically transports prostaglandins and co-localizes with 15-hydroxyprostaglandin dehydrogenase in renal proximal tubules.

Shiraya K, Hirata T, Hatano R, Nagamori S, Wiriyasermkul P, Jutabha P, Matsubara M, Muto S, Tanaka H, Asano S, Anzai N, Endou H, Yamada A, Sakurai H, Kanai Y.

J Biol Chem. 2010 Jul 16;285(29):22141-51. doi: 10.1074/jbc.M109.084426. Epub 2010 May 6.

31.

Identification of a novel organic anion transporter mediating carnitine transport in mouse liver and kidney.

Tsuchida H, Anzai N, Shin HJ, Wempe MF, Jutabha P, Enomoto A, Cha SH, Satoh T, Ishida M, Sakurai H, Endou H.

Cell Physiol Biochem. 2010;25(4-5):511-22. doi: 10.1159/000303060. Epub 2010 Mar 23.

32.

Xenopus laevis oocytes expressing human P-glycoprotein: probing trans- and cis-inhibitory effects on [3H]vinblastine and [3H]digoxin efflux.

Jutabha P, Wempe MF, Anzai N, Otomo J, Kadota T, Endou H.

Pharmacol Res. 2010 Jan;61(1):76-84. doi: 10.1016/j.phrs.2009.07.002. Epub 2009 Jul 21.

PMID:
19631272
33.

Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans.

Anzai N, Ichida K, Jutabha P, Kimura T, Babu E, Jin CJ, Srivastava S, Kitamura K, Hisatome I, Endou H, Sakurai H.

J Biol Chem. 2008 Oct 3;283(40):26834-8. doi: 10.1074/jbc.C800156200. Epub 2008 Aug 13. Erratum in: J Biol Chem. 2008 Nov 14;283(46):32152.

34.

Roles of organic anion transporters in the renal excretion of perfluorooctanoic acid.

Nakagawa H, Hirata T, Terada T, Jutabha P, Miura D, Harada KH, Inoue K, Anzai N, Endou H, Inui K, Kanai Y, Koizumi A.

Basic Clin Pharmacol Toxicol. 2008 Jul;103(1):1-8. doi: 10.1111/j.1742-7843.2007.00155.x. Epub 2008 Jul 1.

35.

Role of mouse organic anion transporter 3 (mOat3) as a basolateral prostaglandin E2 transport pathway.

Nilwarangkoon S, Anzai N, Shiraya K, Yu E, Islam R, Cha SH, Onozato ML, Miura D, Jutabha P, Tojo A, Kanai Y, Endou H.

J Pharmacol Sci. 2007 Jan;103(1):48-55. Epub 2007 Jan 13.

36.

Modulation of renal apical organic anion transporter 4 function by two PDZ domain-containing proteins.

Miyazaki H, Anzai N, Ekaratanawong S, Sakata T, Shin HJ, Jutabha P, Hirata T, He X, Nonoguchi H, Tomita K, Kanai Y, Endou H.

J Am Soc Nephrol. 2005 Dec;16(12):3498-506. Epub 2005 Oct 19.

37.

Functional characterization of rat organic anion transporter 5 (Slc22a19) at the apical membrane of renal proximal tubules.

Anzai N, Jutabha P, Enomoto A, Yokoyama H, Nonoguchi H, Hirata T, Shiraya K, He X, Cha SH, Takeda M, Miyazaki H, Sakata T, Tomita K, Igarashi T, Kanai Y, Endou H.

J Pharmacol Exp Ther. 2005 Nov;315(2):534-44. Epub 2005 Aug 3.

PMID:
16079298
38.

Integrated physiology of proximal tubular organic anion transport.

Anzai N, Jutabha P, Kanai Y, Endou H.

Curr Opin Nephrol Hypertens. 2005 Sep;14(5):472-9. Review.

PMID:
16046907
39.

Interactions of stevioside and steviol with renal organic anion transporters in S2 cells and mouse renal cortical slices.

Srimaroeng C, Jutabha P, Pritchard JB, Endou H, Chatsudthipong V.

Pharm Res. 2005 Jun;22(6):858-66. Epub 2005 Jun 8.

PMID:
15948029
40.

Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorder.

Kleta R, Romeo E, Ristic Z, Ohura T, Stuart C, Arcos-Burgos M, Dave MH, Wagner CA, Camargo SR, Inoue S, Matsuura N, Helip-Wooley A, Bockenhauer D, Warth R, Bernardini I, Visser G, Eggermann T, Lee P, Chairoungdua A, Jutabha P, Babu E, Nilwarangkoon S, Anzai N, Kanai Y, Verrey F, Gahl WA, Koizumi A.

Nat Genet. 2004 Sep;36(9):999-1002. Epub 2004 Aug 1.

PMID:
15286787
41.

Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules.

Ekaratanawong S, Anzai N, Jutabha P, Miyazaki H, Noshiro R, Takeda M, Kanai Y, Sophasan S, Endou H.

J Pharmacol Sci. 2004 Mar;94(3):297-304.

42.

Interactions of human organic anion transporters with diuretics.

Hasannejad H, Takeda M, Taki K, Shin HJ, Babu E, Jutabha P, Khamdang S, Aleboyeh M, Onozato ML, Tojo A, Enomoto A, Anzai N, Narikawa S, Huang XL, Niwa T, Endou H.

J Pharmacol Exp Ther. 2004 Mar;308(3):1021-9. Epub 2003 Nov 10.

PMID:
14610216
43.

Identification of a novel system L amino acid transporter structurally distinct from heterodimeric amino acid transporters.

Babu E, Kanai Y, Chairoungdua A, Kim DK, Iribe Y, Tangtrongsup S, Jutabha P, Li Y, Ahmed N, Sakamoto S, Anzai N, Nagamori S, Endou H.

J Biol Chem. 2003 Oct 31;278(44):43838-45. Epub 2003 Aug 20.

44.

Identification of a novel voltage-driven organic anion transporter present at apical membrane of renal proximal tubule.

Jutabha P, Kanai Y, Hosoyamada M, Chairoungdua A, Kim DK, Iribe Y, Babu E, Kim JY, Anzai N, Chatsudthipong V, Endou H.

J Biol Chem. 2003 Jul 25;278(30):27930-8. Epub 2003 May 10.

45.

Molecular identification of a renal urate anion exchanger that regulates blood urate levels.

Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, Cha SH, Hosoyamada M, Takeda M, Sekine T, Igarashi T, Matsuo H, Kikuchi Y, Oda T, Ichida K, Hosoya T, Shimokata K, Niwa T, Kanai Y, Endou H.

Nature. 2002 May 23;417(6887):447-52. Epub 2002 Apr 14.

PMID:
12024214
46.

Effect of steviol on para-aminohippurate transport by isolated perfused rabbit renal proximal tubule.

Chatsudthipong V, Jutabha P.

J Pharmacol Exp Ther. 2001 Sep;298(3):1120-7.

PMID:
11504809
47.

Effect of stevioside on PAH transport by isolated perfused rabbit renal proximal tubule.

Jutabha P, Toskulkao C, Chatsudthipong V.

Can J Physiol Pharmacol. 2000 Sep;78(9):737-44.

PMID:
11007537
48.

Effects of inhibitors and substitutes for chloride in lumen on p-aminohippurate transport by isolated perfused rabbit renal proximal tubules.

Chatsudthipong V, Jutabha P, Evans KK, Dantzler WH.

J Pharmacol Exp Ther. 1999 Mar;288(3):993-1001.

PMID:
10027836
49.

The relationship between pigment deposits and lesions in normal and centrilobular emphysematous lungs.

PRATT PC, JUTABHA P, KLUGH GA.

Am Rev Respir Dis. 1963 Feb;87:245-56. No abstract available.

PMID:
13985980

Supplemental Content

Loading ...
Support Center